2021
DOI: 10.1016/j.jinorgbio.2021.111590
|View full text |Cite
|
Sign up to set email alerts
|

Pd(II) complexes with chelating N-(1-alkylpyridin-4(1H)-ylidene)amide (PYA) ligands: Synthesis, characterization and evaluation of anticancer activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
8
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 20 publications
(9 citation statements)
references
References 54 publications
1
8
0
Order By: Relevance
“…With respect to other palladium(II) complexes reported, some of them have better biological results than ours at the same incubation times [ 28 , 30 , 32 ]. In contrast, our results improved some of the IC 50 values achieved with other palladium(II) compounds, thereby decreasing the concentration of some of them at the same incubation times, and even having lower IC 50 at shorter incubation times (24 h) [ 29 , 31 , 32 ]. Moreover, compared to closer structures to the ones presented in this work, we were not able to improve the biological activity of a complex previously synthesized by our lab (PdTdTn) on the U937 cell line [ 13 ].…”
Section: Resultsmentioning
confidence: 55%
See 1 more Smart Citation
“…With respect to other palladium(II) complexes reported, some of them have better biological results than ours at the same incubation times [ 28 , 30 , 32 ]. In contrast, our results improved some of the IC 50 values achieved with other palladium(II) compounds, thereby decreasing the concentration of some of them at the same incubation times, and even having lower IC 50 at shorter incubation times (24 h) [ 29 , 31 , 32 ]. Moreover, compared to closer structures to the ones presented in this work, we were not able to improve the biological activity of a complex previously synthesized by our lab (PdTdTn) on the U937 cell line [ 13 ].…”
Section: Resultsmentioning
confidence: 55%
“…The IC 50 values found for these two complexes were between 46.39 ± 3.99 μM and 62.74 ± 6.45 μM in the three lines, with no existing strong differences between the complexes or the cell lines ( Figure 2 A–C and Table 5 ). As reported in previous publications, other palladium(II) complexes have been studied on tumor cells, but in general with longer incubation times (48–72 h) [ 28 , 29 , 30 , 31 , 32 ]. To properly compare our findings with the literature, the cytotoxicity assay was also performed at 48 and 72 h in HeLa cells.…”
Section: Resultsmentioning
confidence: 99%
“…After treatment, cell viability was assessed by introducing 20 μl of fresh MTS solution into each well, allowing them to incubate for three hours, and then measuring the absorbance at 490 nm. 14,35…”
Section: Methodsmentioning
confidence: 99%
“…The known methylated and new benzylated meta pincer-PYA pro-ligands (H 2 L m Me (OTf) 2 and H 2 L m Bn (Cl) 2 were synthesized according to previously reported protocols. 12,29,35 Complexation to zinc and cadmium (C1-C4) was achieved by reacting the pro-ligands with the corresponding metal salts (Zn(OTf) 2 , Cd(CH 3 COO) 2 ) in the presence of DBU as a nonnucleophilic base (Scheme 1). 35 Complexation under these reaction conditions consistently afforded moderate yield.…”
Section: Synthesis and Characterization Of The Compoundsmentioning
confidence: 99%
“…Earlier studies demonstrated that Pd(II) complexes showed strong anticancer activity against different types of tumor cells (18)(19)(20). Studies have also revealed that Pd(II) complexes exhibited a strong cytotoxic effect by inducing apoptosis (18,21,22).…”
Section: Introductionmentioning
confidence: 99%